Aspen Neuroscience, Inc. ASPE
IPO
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Net Income | -19.08M | -17.47M | |||
| Total Depreciation and Amortization | 1.08M | 1.04M | |||
| Total Amortization of Deferred Charges | -- | -- | |||
| Total Other Non-Cash Items | 988.00K | 745.00K | |||
| Change in Net Operating Assets | 860.00K | -2.67M | |||
| Cash from Operations | -16.15M | -18.36M | |||
| Capital Expenditure | -1.87M | -1.95M | |||
| Sale of Property, Plant, and Equipment | -- | -- | |||
| Cash Acquisitions | -- | -- | |||
| Divestitures | -- | -- | |||
| Other Investing Activities | 23.24M | -45.04M | |||
| Cash from Investing | 21.38M | -46.99M | |||
| Total Debt Issued | -- | -- | |||
| Total Debt Repaid | -- | -- | |||
| Issuance of Common Stock | 31.00K | 91.00K | |||
| Repurchase of Common Stock | -- | -- | |||
| Issuance of Preferred Stock | -- | -- | |||
| Repurchase of Preferred Stock | -- | -- | |||
| Total Dividends Paid | -- | -- | |||
| Other Financing Activities | -814.00K | -- | |||
| Cash from Financing | -783.00K | 91.00K | |||
| Foreign Exchange rate Adjustments | -- | -- | |||
| Miscellaneous Cash Flow Adjustments | -- | -- | |||
| Net Change in Cash | 4.45M | -65.26M | |||